The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders affecting the testes, pituitary and hypothalamus, it has not been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved nearly 800 elderly men with low testosterone and symptoms associated with this affliction, for example http://tinyurl.com/zj86oxg physical and sexual dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent conflicting findings on testosterone treatment prompted his team to run a big systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in the United States suffer from low testosterone, which occurs when the body fails to make enough hormones as a result of a problem with the testicles or pituitary gland. This describes the sudden weight gain, apparent aging and loss of energy of an individual.
No clear lower limit of testosterone has been established; yet 15 ng per dL (0.5 nmol per L) commonly is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all situations and absent or markedly decreased orgasms. Due to studies similar to this, supplemented with anecdotal evidence, many girls have been started on testosterone treatment. Most girls can expect to spend one third of their lives in the postmenopausal period. Depression, rage, moodiness, insomnia, and lack of well-being are common criticisms of postmenopausal women.